BlackRock Finance, Inc. - GLYCOMIMETICS INC ownership

GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 40 filers reported holding GLYCOMIMETICS INC in Q2 2024. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of GLYCOMIMETICS INC
ValueSharesWeighting
Q2 2024$203,649
-90.7%
723,184
-1.3%
0.00%
Q1 2024$2,197,701
+26.7%
732,567
-0.3%
0.00%
Q4 2023$1,734,560
+57.4%
734,983
+0.0%
0.00%
Q3 2023$1,102,058
-19.2%
734,704
-6.3%
0.00%
Q2 2023$1,363,994
+66.8%
783,905
+20.8%
0.00%
Q1 2023$817,633
-64.4%
648,915
-14.5%
0.00%
Q4 2022$2,298,849
+443.5%
758,696
-0.9%
0.00%
Q3 2022$423,000
-7.8%
765,885
-0.3%
0.00%
Q2 2022$459,000
-53.6%
768,333
-11.5%
0.00%
Q1 2022$990,000
-21.2%
868,237
-0.5%
0.00%
Q4 2021$1,257,000
-34.4%
872,858
-0.3%
0.00%
Q3 2021$1,917,000
-6.8%
875,151
-1.2%
0.00%
Q2 2021$2,057,000
-75.8%
886,148
-68.6%
0.00%
Q1 2021$8,499,000
-13.6%
2,823,587
+7.9%
0.00%
Q4 2020$9,839,000
+9.2%
2,616,477
-10.9%
0.00%
Q3 2020$9,010,000
-19.4%
2,934,925
-1.3%
0.00%
Q2 2020$11,179,000
+76.8%
2,973,315
+7.2%
0.00%
Q1 2020$6,322,000
-57.8%
2,772,420
-2.0%
0.00%
-100.0%
Q4 2019$14,964,000
+18.5%
2,828,511
-3.5%
0.00%0.0%
Q3 2019$12,628,000
-63.0%
2,929,850
+2.3%
0.00%0.0%
Q2 2019$34,147,000
-5.1%
2,864,664
-0.8%
0.00%
-50.0%
Q1 2019$35,970,000
+33.5%
2,886,908
+1.5%
0.00%
+100.0%
Q4 2018$26,941,000
-34.4%
2,844,893
-0.3%
0.00%
-50.0%
Q3 2018$41,090,000
-9.1%
2,853,504
+1.8%
0.00%0.0%
Q2 2018$45,214,000
+134.9%
2,803,151
+136.4%
0.00%
+100.0%
Q1 2018$19,245,000
+15.6%
1,185,776
+19.5%
0.00%0.0%
Q4 2017$16,655,000
+126.9%
991,948
+89.1%
0.00%
Q3 2017$7,340,000
+35.7%
524,610
+8.2%
0.00%
Q2 2017$5,409,000
+93.8%
484,759
-5.7%
0.00%
Q1 2017$2,791,000
+92933.3%
513,858
+109933.8%
0.00%
Q4 2016$3,0000.0%4670.0%0.00%
Q3 2016$3,0000.0%4670.0%0.00%
Q2 2016$3,0004670.00%
Other shareholders
GLYCOMIMETICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
BVF INC/IL 2,426,282$17,348,0003.27%
NEA Management Company, LLC 8,584,128$61,377,0002.76%
SPHERA FUNDS MANAGEMENT LTD. 718,080$5,134,0000.84%
WALL STREET ASSOCIATES 150,000$1,072,0000.36%
Cormorant Asset Management, LP 287,031$2,052,0000.23%
Candriam S.C.A. 160,000$1,144,0000.03%
PRENTISS SMITH & CO INC 7,000$50,0000.03%
Baker Brothers Advisors 381,235$2,726,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,764$785,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 2,762,807$19,754,0000.01%
View complete list of GLYCOMIMETICS INC shareholders